<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D. C.  20549

                                   FORM 10-Q

(MARK ONE)
[ X ]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1995,
OR
[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _________ TO _________


COMMISSION FILE NO. 0-10235

                               GENTEX CORPORATION
             (Exact name of registrant as specified in its charter)

           MICHIGAN                                     38-2030505
(State or other jurisdiction of           (I.R.S. Employer Identification No.)
incorporation or organization)

     600 N. CENTENNIAL, ZEELAND, MICHIGAN                          49464
   (Address of principal executive offices)                      (Zip Code)

                                 (616) 772-1800
              (Registrant's telephone number, including area code)

     ___________________________________________________________________
             (Former name, former address and former fiscal year,
                        if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

          Yes        x              No
                 ---------               ----------

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE
PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court.  

          Yes                       No
                 ---------               ----------

APPLICABLE ONLY TO CORPORATE USERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.


<TABLE>
<CAPTION>
                                                                            Shares Outstanding
                                Class                                        at July 13, 1995
                                -----                                        ----------------
                 <S>                                                         <C>
                    Common Stock, $0.06 Par Value                               16,733,173
</TABLE>




                       Exhibit Index located at page   11


                                  Page 1 of 15

<PAGE>   2


PART I.         FINANCIAL INFORMATION


ITEM 1.         CONSOLIDATED FINANCIAL STATEMENTS

                      GENTEX CORPORATION AND SUBSIDIARIES

                     CONDENSED CONSOLIDATED BALANCE SHEETS

                    At June 30, 1995 and December 31, 1994



<TABLE>
<CAPTION>
                                                ASSETS
                                                                      June 30, 1995         December 31, 1994
                                                                      -------------         -----------------
<S>                                                                 <C>                     <C>
CURRENT ASSETS
   Cash and cash equivalents                                            $16,298,689           $11,183,991 
   Short term investments                                                15,683,471             8,146,964 
   Accounts receivable, net                                              12,183,338            11,086,980 
   Inventories                                                            5,325,198             5,303,552 
   Prepaid expenses and other                                               735,125               715,466 
                                                                        -----------           -----------
      Total current assets                                               50,225,821            36,436,953 

PLANT AND EQUIPMENT - NET                                                17,903,791            17,172,523 

OTHER ASSETS
   Long-term investments                                                 24,044,983            26,282,085 
   Patents and other assets, net                                          2,123,961               598,918 
                                                                        -----------           -----------

      Total other assets                                                 26,168,944            26,881,003 
                                                                        -----------           -----------

Total assets                                                            $94,298,556           $80,490,479 
                                                                        ===========           ===========


                                LIABILITIES AND SHAREHOLDERS' INVESTMENT

CURRENT LIABILITIES
   Accounts payable                                                     $ 5,919,811           $ 4,115,391 
   Accrued liabilities                                                    4,833,324             4,621,936 
                                                                        -----------           -----------

      Total current liabilities                                          10,753,135             8,737,327 

DEFERRED INCOME TAXES                                                       928,561               377,691 

SHAREHOLDERS' INVESTMENT                        
   Common stock, par value $.06 per share                                 1,003,990               990,569 
   Additional paid-in capital                                            34,603,295            31,875,455 
   Retained earnings                                                     47,993,556            39,409,938 
   Deferred compensation                                                   (971,588)             (899,136)
   Unrealized loss on securities available for sale                         (24,687)                    0
   Cumulative translation adjustment                                         12,294                (1,365)
                                                                        -----------           -----------

      Total shareholders' investment                                     82,616,860            71,375,461 
                                                                        -----------           -----------

Total liabilities and
   shareholders' investment                                             $94,298,556           $80,490,479 
                                                                        ===========           ===========
</TABLE>



     See accompanying notes to condensed consolidated financial statements.


                                     - 2 -






<PAGE>   3

                      GENTEX CORPORATION AND SUBSIDIARIES

                  CONDENSED CONSOLIDATED STATEMENTS OF INCOME



<TABLE>
<CAPTION>
                                          Three Months Ended                   Six Months Ended
                                                June 30                             June 30
                                        -------------------------          --------------------------
                                           1995          1994                  1995          1994
                                        -----------  ------------          ------------  ------------
<S>                                     <C>          <C>                   <C>            <C>

NET SALES                               $26,020,719   $20,708,682           $52,063,687   $41,867,472 

COST OF GOODS SOLD                       15,947,030    11,652,930            31,373,435    23,576,765 
                                        -----------   -----------           -----------   -----------

      Gross profit                       10,073,689     9,055,752            20,690,252    18,290,707 
                                        -----------   -----------           -----------   -----------


OPERATING EXPENSES:
   Research and development               1,530,822     1,201,679             2,919,372     2,419,245 
   Selling, general
      & administrative                    3,344,416     2,275,040             6,413,300     4,461,062 
                                        -----------   -----------           -----------   -----------

      Total operating expenses            4,875,238     3,476,719             9,332,672     6,880,307 
                                        -----------   -----------           -----------   -----------

      Income from operations              5,198,451     5,579,033            11,357,580    11,410,400 
                                        -----------   -----------           -----------   -----------


OTHER INCOME (EXPENSE)
   Interest, net                            686,720       368,204             1,313,937       658,692 
   Other                                     (9,735)       53,557                52,101        57,495 
                                        -----------   -----------           -----------   -----------

      Total other income                    676,985       421,761             1,366,038       716,187 
                                        -----------   -----------           -----------   -----------

      Income before provision
         for federal income taxes         5,875,436     6,000,794            12,723,618    12,126,587 

PROVISION FOR FEDERAL INCOME TAXES        1,879,000     2,011,000             4,140,000     4,035,000 
                                        -----------   -----------           -----------   -----------


NET INCOME                               $3,996,436    $3,989,794            $8,583,618    $8,091,587 
                                        ===========   ===========           ===========   ===========

EARNINGS PER SHARE                            $0.23         $0.23                 $0.50         $0.48


WEIGHTED DAILY AVERAGE OF
COMMON STOCK OUTSTANDING                 17,082,452    17,072,308            17,074,695    16,979,390 
</TABLE>




     See accompanying notes to condensed consolidated financial statements.



                                     - 3 -


<PAGE>   4

                      GENTEX CORPORATION AND SUBSIDIARIES

                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

               For the Six Months Ended June 30, 1995 and 1994




<TABLE>
<CAPTION>
                                                                                                   1995                  1994
                                                                                               -----------           -----------
        <S>                                                                                     <C>                 <C>
        CASH FLOWS FROM OPERATING ACTIVITIES:
           Net income                                                                           $8,583,618            $8,091,587 
           Adjustments to reconcile net income to net
              cash provided by operating activities-
                 Depreciation and amortization                                                   1,588,834             1,390,989 
                 Gain on disposal of equipment                                                      (9,040)                    0
                 Deferred income taxes                                                             655,379               382,266 
                 Amortization of deferred compensation                                             147,299               188,569 
                 Change in assets and liabilities:
                    Accounts receivable, net                                                    (1,096,358)           (1,100,885)
                    Inventories                                                                    (21,646)              123,794 
                    Prepaid expenses and other                                                    (124,168)              (10,600)
                    Accounts payable                                                             1,804,420             1,258,292 
                    Accrued liabilities                                                            211,388              (326,777)
                                                                                               -----------            ----------
                Net cash provided by
                   operating activities                                                         11,739,726             9,997,235 
                                                                                               -----------            ----------

        CASH FLOWS FROM INVESTING ACTIVITIES:
           Decrease (Increase) in short-term investments                                        (7,536,507)              937,616 
           Plant and equipment additions                                                        (2,279,044)           (1,940,110)
           Proceeds from sale of plant and equipment                                                 5,000                     0
           Decrease (Increase) in long-term investments                                          2,212,415           (10,982,386)
           Increase in other assets                                                             (1,548,403)              (72,282)
                                                                                               -----------            ----------
                Net cash used for
                   investing activities                                                         (9,146,539)          (12,057,162)
                                                                                               -----------            ----------

        CASH FLOWS FROM FINANCING ACTIVITIES:
           Issuance of common stock and tax benefit of
             stock plan transactions                                                             2,521,511             3,364,396 
                                                                                               -----------            ----------
                Net cash provided by
                   financing activities                                                          2,521,511             3,364,396 
                                                                                               -----------            ----------


        NET INCREASE IN CASH AND
           CASH EQUIVALENTS                                                                      5,114,698             1,304,469 

        CASH AND CASH EQUIVALENTS,
           beginning of period                                                                  11,183,991             5,979,530 
                                                                                               -----------            ----------

        CASH AND CASH EQUIVALENTS,
           end of period                                                                       $16,298,689            $7,283,999 
                                                                                               ===========            ==========


</TABLE>


     See accompanying notes to condensed consolidated financial statements




                                     - 4 -






<PAGE>   5

                     GENTEX  CORPORATION  AND  SUBSIDIARIES


                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


(1)      The condensed consolidated financial statements included herein have
         been prepared by the Registrant, without audit, pursuant to the rules
         and regulations of the Securities and Exchange Commission.  Certain
         information and footnote disclosures normally included in financial
         statements prepared in accordance with generally accepted accounting
         principles have been condensed or omitted pursuant to such rules and
         regulations, although the Registrant believes that the disclosures are
         adequate to make the information presented not misleading.  It is
         suggested that these condensed consolidated financial statements be
         read in conjunction with the financial statements and notes thereto
         included in the Registrant's 1994 annual report on Form 10-K.

(2)      In the opinion of management, the accompanying unaudited condensed
         consolidated financial statements contain all adjustments, consisting
         of only a normal and recurring nature, necessary to present fairly the
         financial position of the Registrant as of June 30, 1995, and
         December 31, 1994, and the results of operations and cash flows for
         the interim periods presented.

(3)      Inventories consisted of the following at the respective quarter end:


<TABLE>
<CAPTION>
                                                   June 30, 1995             December 31, 1994
                                                   -------------             -----------------
             <S>                                    <C>                          <C>
             Raw materials                          $3,327,930                   $3,568,074
             Work-in-process                           275,183                      275,183
             Finished goods                          1,722,085                    1,460,295
                                                   -----------                  -----------
                                                    $5,325,198                   $5,303,552
                                                   ===========                  ===========
</TABLE>


(4)      The Company owns four U.S. Patents for automatic mirrors and
         electrochromic devices that were the subject of patent infringement
         claims asserted against Donnelly Corporation ("Donnelly") during 1990
         to 1993.  All of those claims, except for the patent infringement
         claim against the Donnelly "Polychromic" rearview mirror, have either
         been adjudicated or were resolved in a settlement in May 1993.  Gentex
         received $3.6 million in damages and settlement fees.

         Despite the May 1993 settlement agreement, in November 1993, Donnelly
         requested that the U.S. Patent and Trademark office (USPTO) re-
         examine certain claims it had granted to Gentex in the Company's U.S.
         Patent No. 5,128,799.  The USPTO agreed to do so, which is not
         unusual, and that re-examination is proceeding.

         In the case of Gentex Corporation vs. Donnelly Corporation (No. 1:93
         CV 430), filed in U.S. District Court for the Western District of
         Michigan, Southern Division, the patent infringement claim against
         Donnelly's "Polychromic" rearview mirror was adjudicated by the
         Federal District Court in March 1994, when it granted Donnelly's
         motion for summary judgment of non-infringement of Gentex U.S. Patent
         No. 5,128,799 by the Donnelly "Polychromic" rearview mirror.  However,
         Gentex appealed that March 1994 judgment to the Court of Appeals for
         the Federal Circuit.  Oral arguments were heard on that appeal in
         November 1994, and a decision is pending.

         The Company also is in litigation with Donnelly on the July 1993 and
         October 1994 suits Donnelly filed for alleged patent infringement by
         the Company's products.  The July 1993 case of Donnelly Corporation
         vs. Gentex Corporation (No. 1:93 CV 530), filed in U.S. District Court
         for the Western District of Michigan, Southern Division, is related to
         alleged infringement of three Donnelly patents directed to the use of
         lights in mirrors ("light and rearview mirror assembly patents") and
         of one Donnelly patent directed to the use of a rearview mirror with a
         dark or color-matched seal ("dark or color-matched seal patent"). The
         Company responded to this suit and denied infringement of each patent,
         asserting that the Donnelly patents are invalid and unenforceable and
         asserting that Donnelly had failed to comply with the patent marking
         statute, precluding recovery of pre-suit damages.

                                      -5-

<PAGE>   6

 NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (CONT.)

(4)      (Cont.)

         Gentex made a motion for summary judgment of invalidity of the
         Donnelly dark or color-matched seal patent in June 1994, and a
         decision on that motion is pending.  Also pending is a decision on
         Donnelly's motion for a preliminary injunction against alleged
         infringement of that same patent.  In April 1995, the Company also
         filed motions for summary judgment of the non-infringement and
         invalidity of the Donnelly "light and rearview mirror assembly
         patents" and motions for partial summary judgment precluding Donnelly
         from recovering any damages for certain acts of alleged infringement.
         A decision also is pending on those motions.

         In April 1995, Donnelly filed five motions for partial summary
         judgment seeking to dismiss certain defenses asserted by the Company
         against the dark or color-matched seal patent and against two of the
         light and rearview mirror assembly patents, and seeking summary
         judgment of the alleged infringement of the dark or color-matched seal
         patent and one of the light and rearview mirror assembly patents.
         Decisions also are pending on those motions.  Both the dark or
         color-matched seal patent and the light and rearview mirror assembly
         patents are scheduled for trial to a jury in October 1995.

         In the October 1994 case of Donnelly Corporation vs. Gentex
         Corporation (No. 1:94 CV 695), filed in U.S. District Court for the
         Western District of Michigan, Southern Division, Donnelly alleged the
         Company's rearview mirror products infringe two Donnelly patents
         directed to the use of ultraviolet stabilizers to protect
         electrochromic mirrors from the harmful effects of ultraviolet
         radiation.  Donnelly also made a motion for a preliminary injunction.
         The Company responded to this suit, denying infringement and asserting
         the Donnelly patents are invalid and unenforceable because Donnelly
         engaged in inequitable conduct before the U.S. Patent and Trademark
         Office in obtaining these patents.  This case is in the discovery
         stage and no trial date has been scheduled.

         In June 1995, the Company filed suit against Donnelly Corporation (No.
         95 CV 120) in the U.S. District Court for the Western District of
         Michigan, Southern Division, for a judgment declaring three Donnelly
         patents to be invalid and not infringed by the Company.  Two of those
         Donnelly patents are directed to rearview mirrors having an optical
         display, such as a compass reading, and the other Donnelly patent is
         directed to rearview mirrors made from a certain type of float glass.
         Discovery is just beginning in this case and no trial date has been
         scheduled.

         While the ultimate results of patent litigation cannot be predicted
         with certainty, management believes that they will not have a material
         adverse effect on the Company's financial statements.

<PAGE>   7

                              GENTEX  CORPORATION


I
TEM 2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF  RESULTS  OF  OPERATIONS
         AND FINANCIAL CONDITION 

         RESULTS OF OPERATIONS:

         SECOND  QUARTER  1995  VERSUS  SECOND QUARTER  1994

         Net Sales.  Net sales for the second quarter of 1995 increased by
         approximately $5,312,000, or 26%, when compared with the second
         quarter last year.  Automatic mirror unit shipments increased from
         approximately 422,000 in the second quarter of 1994 to 507,000 in the
         current quarter.  This increase primarily reflected increased
         penetration on foreign 1995 model year vehicles for interior and
         exterior electrochromic Night Vision Safetya (NVS) Mirrors.  Net
         sales of the Company's fire protection products increased 11%, as
         increased sales to other customers offset reduced shipments of its
         strobe warning light to a major customer that has developed its own
         strobe product.

         Cost of Goods Sold.  As a percentage of net sales, cost of goods sold
         increased from 56% in the second quarter of 1994 to 61% for the
         comparable period in 1995.  This increased percentage primarily
         reflects automotive customer price reductions for the 1995 model year
         and changes in the Company's product mix of automotive mirror
         shipments.

         Operating Expenses.  Research and development expenses increased
         approximately $329,000, but remained at 6% of net sales, when compared
         with the same quarter last year, primarily reflecting additional
         staffing and contractual research and engineering services.  Selling,
         general and administrative expenses increased approximately
         $1,069,000, and increased from 11% to 13% of net sales, when compared
         with the second quarter of 1994.  This increased expense primarily
         reflected higher patent litigation activities.

         Other Income - Net.   Other income increased by approximately $255,000
         when compared with the second quarter of 1994, primarily due to the
         higher investable fund balances and higher interest rates.

         SIX MONTHS ENDED JUNE 30, 1995 VERSUS SIX MONTHS ENDED JUNE 30, 1994

         Net Sales.   Net sales for the six months ended June 30, 1995,
         increased by approximately $10,196,000, or 24%, when compared to the
         same period last year.  Automatic mirror unit shipments increased from
         approximately 839,000 in the first six months of 1994 to 1,025,000 in
         the first six months of 1995.  This increase primarily reflected
         increased penetration on foreign 1995 model year vehicles for interior
         and exterior electrochromic Night Vision Safetya (NVS) Mirrors.  Net
         sales of the Company's fire protection products increased 2% as
         increased sales to other customers offset reduced shipments of its
         strobe warning light to a major customer that has developed its own
         strobe.

         Cost of Goods Sold.  As a percentage of net sales, cost of goods sold
         increased from 56% in the first six months of 1994 to 60% for the
         comparable period in 1995.  This increased percentage primarily
         reflects automotive customer price reductions for the 1995 model year
         and changes to the Company's product mix of automotive mirror
         shipments.

         Operating Expenses.    For the six months ended June 30, 1995,
         research and development expenses increased approximately $500,000,
         but remained at 6% of net sales, when compared to the same period last
         year, primarily reflecting additional staffing and contractual
         research and engineering services.  Selling, general and
         administrative expenses increased approximately $1,952,000, and
         increased from 11% to 12% of net sales, when compared to the first six
         months of 1994.  This increased expense primarily reflected higher
         patent litigation activities.

         Other Income - Net.    Other income for the six months ended June 30,
         1995, increased by approximately $650,000 as compared to the first six
         months of 1994, primarily due to the higher investable fund balances
         and higher interest rates.


                                      -7-

<PAGE>   8

I
TEM 2.  RESULTS OF OPERATIONS  (CONT.) : 


         FINANCIAL CONDITION:

         Management considers the Company's working capital and long-term
         investments totaling approximately $63,518,000 at June 30, 1995,
         together with internally generated cash flow and an unsecured
         $5,000,000 line of credit from a bank, to be sufficient to cover
         anticipated cash needs for the foreseeable future.

         TRENDS AND DEVELOPMENTS:

         The Company currently supplies NVS  Mirrors to Chrysler Corporation,
         Ford Motor Company and General Motors Corporation under long-term
         contracts.  During the quarter, the General Motors contract was
         extended through the 1998 model year, and the Company entered into
         contracts with BMW for the four-year period ending March 31, 1999.
         The term of the Ford contract is through December 1999, and the
         Chrysler contract runs through the 1999 Model Year.

         The Company has agreed to price reductions over the term of its
         long-term contracts and continues to experience pricing pressures from
         its automotive customers, which have and will continue to affect its
         margins to the extent that the Company is unable to fully offset the
         price reductions with productivity improvements, material cost
         reductions and increases in unit sales volume.

         The total costs to defend the Company in the July 8, 1993, and
         October 13, 1994, suits filed by Donnelly Corporation will be affected
         by the duration and activity level, and are not determinable at this
         time.  However, management currently believes that, if the current
         trend continues, patent litigation costs will continue to increase
         with the additional suits and related activity levels, but should peak
         out during the year.


                                     -8-

<PAGE>   9



PART II.        OTHER INFORMATION


       Item 1.  Legal Proceedings

                In May 1995, the Company settled the patent infringement suit
                that was filed by C-D Marketing, Ltd., on February 10, 1994.
                The settlement involved the acquisition by the Company of all
                of the United States and foreign patent rights of C-D
                Marketing, Ltd., for a cash amount that is not material to the
                Company's financial position or results of operations.

                On June 23, 1995, the Company filed suit against Donnelly
                Corporation (No. 95 CV 120) in the U.S. District Court for the
                Western District of Michigan, Southern Division, for a judgment
                declaring three Donnelly patents to be invalid and not
                infringed by the Company.  Two of those Donnelly patents are
                directed to rearview mirrors having an optical display, such as
                a compass reading, and the other Donnelly patent is directed to
                rearview mirrors made from a certain type of float glass.
                Discovery is just beginning in this case and no trial date has
                been scheduled.


       Item 4.  Submission of Matters to a Vote of Security Holders

                The annual meeting of the shareholders of the Company was held
                on May 11, 1995, at which:

                (i)     The following nominees were elected to serve three-year
                        terms on the Company's Board of Directors by the
                        following votes:

<TABLE>
                        <S>             <C>                     <C>
                                           Mickey E. Fouts        John Mulder
                        For                   14,418,698          14,429,298
                        Against                    -                   -
                        Withheld                 273,750             263,150
                        Broker Non-Votes           -                   -
</TABLE>


                The terms of office for incumbent Directors Fred Bauer,
                Harlan Byker, Kenneth La Grand, Ted Thompson and Leo Weber,
                continued after the meeting.

                (ii)    A proposal to approve the Amended and Restated Gentex
                        Corporation Qualified Stock Option Plan was approved by
                        the following vote:

<TABLE>
                            <S>                   <C>
                            For                   8,003,290
                            Against               2,563,907
                            Abstain                 111,100
                            Broker Non-Votes      4,014,151
</TABLE>




Item 6.         Exhibits and Reports on Form 8-K

                (a)     See Exhibit Index on Page 11.

                (b)     No reports on Form 8-K were filed during the three
                        months ended June 30, 1995.





                                      -9-

<PAGE>   10


                                   SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.





                                      GENTEX CORPORATION


        
Date    8/1/95                  /s/ FRED T. BAUER
     -------------              ------------------------------
                                Fred T. Bauer
                                Chairman and Chief
                                Executive Officer




Date    8/1/95                  /s/ ENOCH C. JEN
     -------------              ------------------------------
                                Enoch C. Jen
                                Vice President-Finance,
                                Principal Financial and
                                Accounting Officer





                                      -10-

<PAGE>   11


                                 EXHIBIT INDEX



<TABLE>
<S><C>
EXHIBIT NO.                             DESCRIPTION                                PAGE

3(a)(1)          Registrant's Articles of Incorporation were filed in 1981 as
                 Exhibit 2(a) to a Registration Statement on Form S-18
                 (Registration No. 2-74226C), an Amendment to those Articles
                 was filed as Exhibit 3 to Registrant's Report on Form 10-Q in
                 August of 1985, an additional Amendment to those Articles was
                 filed as Exhibit 3(a)(i) to Registrant's Report on Form 10-Q
                 in August of 1987, and an additional Amendment to those
                 Articles was filed as Exhibit 3(a)(2) to Registrant's Report
                 on Form 10-K dated March 10, 1992, all of which are hereby
                 incorporated herein by reference.

3(a)(2)          Amendment to Articles of Incorporation, adopted on May 12, 1994.

3(b)             Registrant's Bylaws as amended and restated March 1, 1990,
                 were filed as Exhibit 3(b) to Registrant's Report on Form 10-K
                 dated March 1, 1990, and the same is incorporated herein by
                 reference.

4(a)             A specimen form of certificate for the Registrant's common
                 stock, par value $.06 per share, was filed as part of a
                 Registration Statement on Form S-18 (Registration No.
                 2-74226C) as Exhibit 3(a), as amended by Amendment No. 3 to
                 such Registration Statement, and the same is hereby
                 incorporated herein by reference.

4(b)             Shareholder Protection Rights Agreement, dated as of August
                 26, 1991, including as Exhibit A the form of Certificate of
                 Adoption of Resolution Establishing Series of Shares of Junior
                 Participating Preferred Stock of the Company, and as Exhibit B
                 the form of Rights Certificate and of Election to Exercise,
                 was filed as Exhibit 4(b) to Registrant's report on Form 8-K
                 on August 20, 1991, and the same is hereby incorporated herein
                 by reference.

4(b)(1)          First Amendment to Shareholder Protection Rights Agreement,
                 effective April 1, 1994, was filed as Exhibit 4(b)(1) to
                 Registrant's report on Form 10-Q on April 29, 1994, and the
                 same is hereby incorporated herein by reference.

10(a)(1)         A Lease dated August 15, 1981, was filed as part of a
                 Registration Statement (Registration Number 2-74226C) as
                 Exhibit 9(a)(1), and the same is hereby incorporated herein by
                 reference.

10(a)(2)         A First Amendment to Lease dated June 28, 1985, was filed as
                 Exhibit 10(m) to Registrant's Report on Form 10-K dated March
                 18, 1986, and the same is hereby incorporated herein by
                 reference.

*10(b)(1)        Gentex Corporation Qualified Stock Option Plan as amended and
                 restated, effective May 11, 1995.                                 13

*10(b)(2)        Gentex Corporation 1987 Incentive Stock Option Plan (as
                 amended through May 24, 1989), was filed as Exhibit 10(g)(3)
                 to Registrant's Report on Form 10-K dated March 1, 1990, and
                 the same is hereby incorporated herein by reference.

*10(b)(3)        Gentex Corporation Restricted Stock Plan was filed as Exhibit
                 10(b)(3) to Registrant's Report on Form 10-K dated March 10,
                 1992, and the same is hereby incorporated herein by reference.


</TABLE>





                                      -11-

<PAGE>   12




<TABLE>
<CAPTION>
EXHIBIT NO.                               DESCRIPTION                              PAGE
-----------                               -----------                              ----
<S>             <C>                                                                <C>
*10(b)(4)       Gentex Corporation Non-Employee Director Stock Option Plan as
                amended through March 5, 1993, was filed as Exhibit 10(b)(4) to
                Registrant's Report on Form 10-K dated March 5, 1993, and the
                same is incorporated herein in reference.

10(e)           The form of Indemnity Agreement between Registrant and each of
                the Registrant's directors was filed as a part of a
                Registration Statement on Form  S-2 (Registration No. 33-30353)
                as Exhibit 10(k) and the same is hereby incorporated herein by
                reference.

27              Financial Data Schedule
</TABLE>






* Indicates a compensatory plan or arrangement.





                                      -12-

<PAGE>   13
 
                                  
 
                               GENTEX CORPORATION
                          QUALIFIED STOCK OPTION PLAN
               (AS AMENDED AND RESTATED, EFFECTIVE MAY 11, 1995)
 
     1. Purpose.  The purpose of this Plan is to provide an opportunity for
certain employees of Gentex Corporation and its subsidiaries to purchase shares
of capital stock of the Corporation and thereby have an additional incentive to
contribute to the prosperity of the Corporation.
 
     2. Definitions.  The following terms are defined for use herein as follows:
 
          a. "Board" means the Board of Directors of Gentex Corporation.
 
          b. "Common Stock" means the common stock (par value ($.06 per share)
     of Gentex Corporation.
 
          c. "Committee" means the committee appointed pursuant to Paragraph 4
     to administer the Plan.
 
          d. "Corporation" means Gentex Corporation and any subsidiary
     corporation where Gentex Corporation owns fifty percent (50%) or more of
     the combined voting power of all outstanding securities within the meaning
     of the applicable provisions of the Internal Revenue Code.
 
          e. "Effective Date" means the effective date of this Amended and
     Restated Plan, May 11, 1995.
 
          f. "Market Value" means the closing sale price of Common Stock
     reported in The Nasdaq Stock Market for the day on which the particular
     option is granted, or, if prices of shares of Common Stock are not so
     published for that date, then a fair market value determined by the
     Committee by any reasonable method selected by it in good faith.
 
          g. "Optionee" means any employee to whom an option has been granted
     under the Plan.
 
          h. "Option Agreement" means an agreement evidencing options as
     provided in Paragraph 7 of the Plan.
 
          i. "Plan" means this Qualified Stock Option Plan of the Corporation as
     in effect from time to time.
 
          j. "Option Price" means the purchase price for Common Stock under an
     option, as determined under Paragraph 7 of this Plan.
 
     3. Shares.
 
          a. The total number of shares of the Common Stock which may be sold
     under the Plan shall not exceed 2,250,000 shares, except that the total
     number of shares which may be sold under the Plan may be increased to the
     extent of adjustments authorized by Paragraph 10. Such shares shall be
     authorized shares and may be either unissued shares or treasury shares.
 
          b. If an option granted under the Plan shall expire or terminate for
     any reason without having been exercised in full, the shares not delivered
     under such option shall be available for options subsequently granted.
 
     4. Administration.
 
          a. The Plan shall be administered by a Committee appointed by the
     Board, which shall consist of three (3) or more members. All members of the
     Committee shall be directors who are "disinterested persons" within the
     meaning of Rule 16b-3 promulgated by the Securities and Exchange
     Commission. Except as provided in Paragraph 7 f., the Committee shall
     determine the employees to be granted options, the amount of stock to be
     optioned to each employee, and the terms of the options to be granted. The
     Committee shall have full power and authority to interpret the provisions
     of the Plan, to supervise the administration of the Plan and to adopt forms
     and procedures for the administration of the Plan. All determinations made
     by the Committee shall be final and conclusive.
 
                                      13

<PAGE>   14
 
          b. The granting of any option pursuant to this Plan shall be entirely
     within the discretion of the Committee. Nothing herein contained shall be
     construed to give any officer or employee any right to participate under
     this Plan.
 
          c. Each person who is or shall have been a member of the Committee
     shall be indemnified and held harmless by the Corporation from and against
     any cost, liability or expense imposed or incurred in connection with such
     person's or the Committee's taking or failing to take any action under the
     Plan. Each such person may rely on information furnished in connection with
     the Plan's administration by any appropriate person or persons.
 
     5. Eligibility.  Only employees of the Corporation shall be eligible to
participate in the Plan. The Committee shall determine whether or not an
individual is eligible to participate in the Plan. An employee who has been
granted an option under this Plan or any other stock option plan of the
Corporation may be granted additional options.
 
     6. Exercise Price.  The per share exercise price of each option granted
under the Plan shall be at least one hundred percent (100%) of the Market Value
of a share of Common Stock; provided, however, any option granted to a
participant possessing more than ten percent (10%) of the total combined voting
power of all classes of stock of Gentex Corporation shall be at an Option Price
not less than one hundred ten percent (110%) of the market value of a share of
Common Stock and shall not be exercisable after the expiration of five years
from the date the option is granted.
 
     7. Terms of Options.  Each option shall be evidenced by a written agreement
containing such terms and conditions as are set by the Board or the Committee,
including without limitation the following:
 
          a. Number of Shares.  Each Option Agreement shall state the number of
     shares to which it pertains.
 
          b. Exercise Price.  Each Option Agreement shall state the exercise
     price.
 
          c. Medium and Time of Payment.  The exercise price for each share
     purchased pursuant to an option granted under the Plan shall be payable in
     full upon exercise, and may be paid in cash or, in full or in part, by the
     surrender of Common Stock owned by the Optionee valued at fair market value
     or by the surrender of Option rights hereunder that are then exercisable,
     valued at the difference between the Option Price and the fair market value
     of the underlying Common Stock. Promptly after the exercise of an Option
     and the payment of the full Option Price, the Optionee shall be entitled to
     the issuance of a stock certificate evidencing ownership of such Common
     Stock. However, an Optionee shall have none of the rights of a shareholder
     until a certificate for those Shares is issued to the Optionee, and no
     adjustment will be made for dividends or other rights for which the record
     date is prior to the date such stock certificate is issued, except as
     provided in Paragraph 10 of this Plan.
 
          d. Term and Exercise of Options.  Each option shall be exercisable in
     whole or in part in such amounts and at or after such dates as may be
     specified in the option agreement. In no event, however, shall any option
     be exercisable less than one (1) year from the date of grant.
 
          e. Administrative Discretion.  The Committee may in its discretion
     vary, among employees and among options granted to the same employee, any
     and all of the terms and conditions of options granted under the Plan,
     including the term during which and the amounts in which and dates at or
     after which such options may be exercised.
 
          f. Special C.E.O. Terms.  Notwithstanding any other provision of this
     Plan to the contrary, the current chief executive officer of Gentex
     Corporation shall receive, as of the date this Plan is approved by the
     Board, and annually thereafter as of the time his compensation is reviewed
     by the Committee, an option for 15,000 shares of Common Stock, and no other
     options may be granted to that individual under this Plan. These options
     shall become exercisable for twenty percent (20%) of the shares on the
     first anniversary of the grant date and for an additional twenty percent
     (20%) on each anniversary thereafter, and all unexercised options shall
     expire on the seventh anniversary date of the grant.
 
                                      14


<PAGE>   15
 
     8. Transferability of Options and Common Stock.  Options under this Plan
may not be transferred except by will or according to the laws of descent and
distribution. During the lifetime of the Optionee, an option may be exercised
only by the Optionee or his guardian or legal representative. After an
Optionee's death, options that were exercisable at the date of death may be
exercised at any time within one year after the date of death, subject to prior
expiration, by the executor or administrator of the Optionee's estate, any
person(s) who acquired the option directly from the Optionee by bequest or
inheritance, or any person designated specifically in a written designation
signed by the Optionee and filed with the Committee prior to the date of death.
The Corporation may, in the event it deems the same desirable to assure
compliance with applicable federal and state securities laws, legend any
certificate representing shares issued pursuant to the exercise of an option
with an appropriate restrictive legend, and may also issue appropriate stop
transfer instructions to its transfer agent with respect to such shares.
 
     9. Termination of Options.  Each option agreement shall contain such
provisions as the Committee may deem advisable for termination of the option in
the event of, and/or exercise of the option after the Optionee's death,
disability, or termination of employment by the Corporation. No option may be
exercised more than three (3) months after the termination of the Optionee's
employment by the Corporation, nor more than twelve (12) months after the
Optionee shall have died or become disabled, without the specific approval of
the Committee.
 
     Option agreements may also contain, in the discretion of the Committee,
provisions for termination of options and/or acceleration of exercise rights in
the event of any merger or consolidation of the Corporation with, or acquisition
of the Corporation or substantially all of its assets by, any other corporation
or entity.
 
     Nothing in the Plan or in any option shall limit or affect in any way the
right of the Corporation to terminate an Optionee's employment at any time nor
be deemed to confer upon any Optionee any right to continue in the employ of the
Corporation.
 
     10. Adjustment Provision.  If the number of shares of Common Stock
outstanding changes by reason of a stock dividend, stock split,
recapitalization, merger, consolidation, split-up, combination or exchange of
shares, the aggregate number and class of shares available under this Plan and
the number of shares subject to each outstanding option, together with the
option prices, shall be appropriately adjusted by the Board or Committee to
prevent dilution of the interests of Optionees and of the Plan.
 
     11. Effective Date of Plan, Termination and Amendment.  The May 18, 1995
Plan Restatement shall take effect only upon and as of the date of approval of
the Plan by the Corporation's stockholders. Unless earlier terminated by the
Board, the Plan shall terminate on the date ten (10) years subsequent to the
date of the adoption of the Plan Restatement by the Board, after which date no
options may be granted under this Plan. The Board may terminate the Plan at any
time, or may from time to time amend the Plan as it deems proper and in the best
interest of the Corporation, provided that no such amendment may (a) alter the
aggregate number of shares that may be issued under the Plan, (b) decrease the
price at which options may be granted, or (c) modify the eligibility
requirements set forth in Paragraph 5.
 

                                 CERTIFICATION
 
     The foregoing Plan Restatement was duly adopted by the Board of Directors
on the 12th day of August, 1994, subject to the approval of the Company's
shareholders.
 
                                          /s/ CONNIE HAMBLIN
                                          --------------------------------------
                                          Connie Hamblin, Secretary
                                          Gentex Corporation
 
                                      15


<PAGE>   16
[ARTICLE] 5

<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   3-MOS
[FISCAL-YEAR-END]                          DEC-31-1995
[PERIOD-END]                               JUN-30-1995
[CASH]                                      16,298,689
[SECURITIES]                                15,683,471
[RECEIVABLES]                               12,616,141
[ALLOWANCES]                                 (432,803)
[INVENTORY]                                  5,325,198
[CURRENT-ASSETS]                            50,225,821
[PP&E]                                      28,737,598
[DEPRECIATION]                            (10,833,807)
[TOTAL-ASSETS]                              94,298,556
[CURRENT-LIABILITIES]                       10,753,135
[BONDS]                                              0
[COMMON]                                     1,003,990        
[PREFERRED-MANDATORY]                                0
[PREFERRED]                                          0
[OTHER-SE]                                  81,612,870
[TOTAL-LIABILITY-AND-EQUITY]                94,298,556
[SALES]                                     26,020,719
[TOTAL-REVENUES]                            26,020,719
[CGS]                                       15,947,030
[TOTAL-COSTS]                               20,822,268
[OTHER-EXPENSES]                             (676,985)
[LOSS-PROVISION]                                18,500
[INTEREST-EXPENSE]                                   0
[INCOME-PRETAX]                              5,975,436
[INCOME-TAX]                                 1,879,000
[INCOME-CONTINUING]                          3,996,436
[DISCONTINUED]                                       0
[EXTRAORDINARY]                                      0
[CHANGES]                                            0
[NET-INCOME]                                 3,996,436
[EPS-PRIMARY]                                     0.23
[EPS-DILUTED]                                     0.23
</TABLE>